RAKING IT IN AT PATENT U.

So which patents—along with their universities and scientists— are leading the race for royalties? An exact ranking is difficult, thanks to inflation and closely guarded revenue figures. But here are a few of the top contenders, along with notable also-rans. Number One Patent: The biggest income producer of all time is probably cisplatin, a cancer drug developed at Michigan State University and licensed to Bristol-Myers. Royalties for this drug have already topped $55 million̵

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

So which patents—along with their universities and scientists— are leading the race for royalties? An exact ranking is difficult, thanks to inflation and closely guarded revenue figures. But here are a few of the top contenders, along with notable also-rans.

Number One Patent: The biggest income producer of all time is probably cisplatin, a cancer drug developed at Michigan State University and licensed to Bristol-Myers. Royalties for this drug have already topped $55 million—and are continuing at more than $10 million a year with about eight years left on the patent. So far. Michigan State has taken in $15.3 million and inventors Barnett Rosenberg Thomas Krigas. and Loretta L Van Camp have divided another $8 million.

Richest Scientists: One of the top inventions of all time is Gatorade. Since 1973, this thirst-quencher, designed by University of Florida researchers to replace nutrients the body loses in athletic activity, has brought in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies